Cargando…
Alternative Checkpoints as Targets for Immunotherapy
PURPOSE OF REVIEW: Immunotherapy has shown an unprecedented response in treatment of tumors. However, challenges such as lack of cytotoxic lymphocytes to mount an immune response or development of resistance to therapy can limit efficacy. Here, we discuss alternative checkpoints that can be targeted...
Autores principales: | Pant, Ayush, Medikonda, Ravi, Lim, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608303/ https://www.ncbi.nlm.nih.gov/pubmed/33141349 http://dx.doi.org/10.1007/s11912-020-00983-y |
Ejemplares similares
-
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
por: Pirozzi, Flora, et al.
Publicado: (2021) -
Immunology of Lynch Syndrome
por: Pastor, Danielle M., et al.
Publicado: (2021) -
Development of Effective Siglec-9 Antibodies Against Cancer
por: Wang, Jun Hui Shawn, et al.
Publicado: (2022) -
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2021) -
Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock
por: Almaida-Pagan, Pedro F., et al.
Publicado: (2022)